• Exchanges

NIH to fund Next Generation MPTs

The National Institutes of Health has released a new funding solicitation to support development of the next generation of multipurpose prevention technologies (MPTs).  Proposed research should focus on designing/testing MPTs that prevent pregnancy and HIV infection in women.  MPTs must combine a licensed contraceptive and an anti-HIV drug delivered using drug delivery systems with rheological/biophysical properties and product user perceptions (look, feel, effectiveness, safety and duration of action) compatible with current long-acting reversible contraceptive strategies.

NIH support will be two-pronged— Research for Phase 1 will be funded for up to three years using an R-61 mechanism ($800,000 in annual direct costs).  Up to two years of additional funding for Phase 2 activities will be provided through an R-33 ($1,600,000 in annual direct costs).

Applications are due March 19, 2018.  NIH intends to fund two or three awards, with projects expected to start in December 2018.

Get in touch with us

  • Twitter
linkedin social bar.png

Powered by